Drugs / moxypen
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT02819570 Comparator | Nov 2015 → Dec 2017 | preterm premature rupture of the membranes | Western Galilee Hospital-Nahariya | Unknown | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | moxypen | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02819570 ↗ |
| Route | Oral | “P.O moxypen 500 mgx3/d for 5 days” NCT02819570 ↗ |